| CARDIOL THERAPEUTICS CL.A |
| Kanada |
| Gesundheit |
| CA14161Y2006 / A2PA9E |
| CT9 (Frankfurt) / CRDL (NASDAQ) |
| FRA:CT9, ETR:CT9, CT9:GR, NASDAQ:CRDL |
| - |
| https://www.cardiolrx.com.. |
|
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company that focuses on developing innovative therapies for heart diseases. The company's primary objective is to research and produce anti-inflammatory and anti-fibrotic treatments aimed at..
>Volltext.. |
| 148.13 Mio. EUR |
| 131.01 Mio. EUR |
| - |
| -22.08 Mio. EUR |
| -22.62 Mio. EUR |
| -0.24 EUR |
| 0.07 Mio. EUR |
| 17.22 Mio. EUR |
| -15.07 Mio. EUR |
| 3.88 |
| - |
| 1.59% |
| - |
| - |
| - |
| - |
| CARDIOL |
| 13.08.26 |
|
||||
|